
Article 1 
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Article 2 
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 8 April 2016.
For the Commission
The President
Jean-Claude JUNCKER
ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

((1)) in the sixth column, expiration of approval, of row 11, Bentazone, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’;
((2)) in the sixth column, expiration of approval, of row 15, Diquat, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’;
((3)) in the sixth column, expiration of approval, of row 17, Thiabendazole, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’;
((4)) in the sixth column, expiration of approval, of row 19, DPX KE 459 (flupyrsulfuron-methyl), the date of ‘30 June 2016’ is replaced by ‘30 June 2017’;
((5)) in the sixth column, expiration of approval, of row 23, Pymetrozine, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’;
((6)) in the sixth column, expiration of approval, of row 26, Thifensulfuron-methyl, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’;
((7)) in the sixth column, expiration of approval, of row 31, Prosulfuron, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’;
((8)) the sixth column, expiration of approval, of row 34, Cyhalofop butyl, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’;
((9)) in the sixth column, expiration of approval, of row 35, Famoxadone, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’;
((10)) in the sixth column, expiration of approval, of row 37, Metalaxyl-M, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’;
((11)) in the sixth column, expiration of approval, of row 38, Picolinafen, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’;
((12)) in the sixth column, expiration of approval, of row 39, Flumioxazine, the date of ‘30 June 2016’ is replaced by ‘30 June 2017’.
